Fortis Malar Hospitals
Close ·
- P/E
- 576.00
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- 14.60%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹0.07
- Book Value
- ₹18.32
- Market Cap
- —
- P/E (TTM)
- 576.00
- P/B
- 2.20
- ROE
- 12.80%
- Dividend Yield
- 107.32%
- EBITDA
- ₹4.70 Cr
- 52W High
- ₹66.99
- 52W Low
- ₹39.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 53
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 33
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 92
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 86
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 17
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of -1.79% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 45.17
- Neutral
- MACD (12,26,9)
- −0.68
- Bullish
- SMA (50)
- 42.38
- Bearish
- SMA (200)
- 50.20
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | −100.00% |
|---|---|
| 5Y | −100.00% |
| 3Y | −100.00% |
| 1Y | Zero base |
| TTM | +50.00% |
Net profit
| 10Y | −4.29% |
|---|---|
| 5Y | Turned to profit |
| 3Y | Turned to profit |
| 1Y | +961.54% |
| TTM | −97.18% |
Operating cash flow
| 10Y | −24.62% |
|---|---|
| 5Y | Turned positive |
| 3Y | −52.01% |
| 1Y | −59.74% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | No sales |
| 3Y | No sales |
| 1Y | No sales |
| TTM | Tiny sales |
Revenue by year
| Mar 2017 | ₹141 Cr |
|---|---|
| Mar 2018 | ₹149 Cr |
| Mar 2019 | ₹145 Cr |
| Mar 2020 | ₹112 Cr |
| Mar 2021 | ₹69.24 Cr |
| Mar 2022 | ₹86.18 Cr |
| Mar 2023 | ₹85.95 Cr |
| Mar 2024 | ₹59.01 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.00 Cr |
Net profit by year
| Mar 2017 | ₹3.11 Cr |
|---|---|
| Mar 2018 | ₹3.32 Cr |
| Mar 2019 | ₹2.06 Cr |
| Mar 2020 | −₹8.89 Cr |
| Mar 2021 | −₹7.87 Cr |
| Mar 2022 | −₹8.27 Cr |
| Mar 2023 | −₹15.48 Cr |
| Mar 2024 | ₹45.32 Cr |
| Mar 2025 | ₹0.39 Cr |
| Mar 2026 | ₹4.14 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.76 | 18.15 | 17.58 | 5.52 | 0 | 0 | 0 | 0 | 0.02 | 0.03 | 0 | 0 | 0 |
| Expenses | 18.27 | 18.23 | 18.67 | 5.04 | 0.88 | 0.47 | 0.41 | 0.37 | 0.35 | 0.41 | 0.33 | 0.55 | 0.33 |
| Operating Profit | −0.51 | −0.08 | −1.09 | 0.48 | −0.88 | −0.47 | −0.41 | −0.37 | −0.33 | −0.38 | −0.33 | −0.55 | −0.33 |
| OPM % | −2.87% | −0.44% | −6.2% | 8.7% | — | — | — | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | — |
| Other Income | 1.61 | 2.31 | 1.26 | 59.69 | 0.83 | 0.56 | 0.56 | 0.77 | 4.61 | 0.52 | 0.52 | 0.66 | 0.53 |
| Interest | 1.35 | 1.3 | 1.26 | 0.39 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2.67 | 2.72 | 2.91 | 1.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −2.92 | −1.79 | −4 | 58.72 | −0.06 | 0.09 | 0.15 | 0.4 | 4.28 | 0.14 | 0.19 | 0.11 | 0.2 |
| Tax % | 0% | 0% | 0.25% | 7.95% | 0% | 0% | 93.33% | 10% | 3.04% | 92.86% | 89.47% | 136.36% | 25% |
| Net Profit | −2.93 | −1.79 | −4 | 54.05 | −0.06 | 0.09 | 0.01 | 0.36 | 4.15 | 0.01 | 0.02 | −0.05 | 0.15 |
| EPS (₹) | −1.56 | −0.96 | −2.13 | 28.84 | −0.03 | 0.05 | 0.01 | 0.19 | 2.21 | 0.01 | 0.01 | −0.03 | 0.08 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 118 | 130 | 141 | 149 | 145 | 112 | 69.24 | 86.18 | 85.95 | 59.01 | 0 | 0 | 0.03 |
| Expenses | 110 | 123 | 140 | 147 | 147 | 115 | 75.58 | 82.74 | 81.38 | 60.22 | 2.14 | 1.62 | 1.62 |
| Operating Profit | 7.56 | 6.3 | 0.92 | 1.75 | −2.35 | −2.7 | −6.34 | 3.44 | 4.57 | −1.21 | −2.14 | −1.62 | −1.59 |
| OPM % | 6.41% | 4.86% | 0.65% | 1.17% | −1.63% | −2.41% | −9.16% | 3.99% | 5.32% | −2.05% | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| Other Income | 7.63 | 7.21 | 7.95 | 8.44 | 10.03 | 11.11 | 15.1 | 7.39 | 6.64 | 64.88 | 2.72 | 6.35 | 2.23 |
| Interest | 0.51 | 0.4 | 0.46 | 0.38 | 0.51 | 7.81 | 7.2 | 6.56 | 6.07 | 4.3 | 0.01 | 0 | 0 |
| Depreciation | 2.71 | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | 0 | 0 | 0 |
| PBT | 11.97 | 9.95 | 4.47 | 5.6 | 2.79 | −11.93 | −11.32 | −8.26 | −7.01 | 50.01 | 0.57 | 4.73 | 0.64 |
| Tax % | 34.25% | 35.58% | 30.2% | 40.54% | 26.16% | −25.48% | −30.48% | 0.12% | 120.97% | 9.36% | 31.58% | 12.47% | — |
| Net Profit | 7.86 | 6.42 | 3.11 | 3.32 | 2.06 | −8.89 | −7.87 | −8.27 | −15.48 | 45.32 | 0.39 | 4.14 | 0.13 |
| EPS (₹) | 4.23 | 3.45 | 1.67 | 1.78 | 1.1 | −4.74 | −4.2 | −4.41 | −8.26 | 24.18 | 0.21 | 2.21 | 0.07 |
| Div. Payout % | 11.84% | 14.5% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 175.93% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18.61 | 18.62 | 18.68 | 18.7 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
| Reserves | 72.63 | 79.02 | 80.87 | 84.35 | 86.62 | 77.65 | 69.99 | 61.37 | 45.42 | 90.71 | 11.45 | 15.59 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 64.34 | 57.17 | 53.41 | 46.4 | 0 | 0 | 0 |
| Other Liabilities | 19.68 | 32.55 | 31.14 | 46.03 | 45.46 | 32.8 | 23.18 | 27.37 | 27.42 | 6.41 | 6.62 | 3.26 |
| Total Liabilities | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 36.83 | 37.61 |
| Fixed Assets | 17.71 | 24.5 | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | 0 | 0 | 0 |
| CWIP | 0.64 | 0.36 | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 92.57 | 105 | 105 | 125 | 128 | 112 | 100 | 103 | 90.59 | 116 | 36.83 | 37.61 |
| Total Assets | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 36.83 | 37.61 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 4.39 | 10.47 | −8.58 | 8.79 | −15.97 | −0.3 | −0.86 | 6.84 | 5.61 | −7.3 | 1.54 | 0.62 |
| Investing | 5.34 | −21.88 | 13.47 | −1.56 | 6.34 | 49.88 | −27.51 | 8.23 | 0.5 | 120 | −29.1 | 0.46 |
| Financing | 0 | −1.09 | −0.97 | 0.05 | 0.15 | −11.57 | −7.25 | −10.1 | −12.65 | −10.85 | −79.65 | 0 |
| Net Cash Flow | 9.73 | −12.51 | 3.92 | 7.28 | −9.48 | 38.01 | −35.62 | 4.98 | −6.54 | 102 | −107 | 1.08 |
| Free Cash Flow | 1.11 | −0.1 | −12.14 | 5.11 | −18.68 | −3.2 | −1.39 | 5.56 | 3.73 | −9.6 | 1.54 | 0.62 |
| CFO/OP | 133 | 235 | −175 | 801 | 458 | −143 | 204 | 220 | 121 | 188 | 81 | 51 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.03 | 16.93 | 14.49 | 14.68 | 24.39 | 12.17 | 11.02 | 9.32 | 13.5 | 0 | — | — |
| Inventory Days | 13.24 | 35.39 | 28.37 | 22.3 | 18.04 | 22.44 | 42.32 | 39.89 | 31.71 | 0 | — | — |
| Days Payable | 169 | 286 | 174 | 277 | 257 | 324 | 373 | 429 | 585 | — | — | — |
| Cash Conversion Cycle | −143 | −234 | −131 | −240 | −215 | −289 | −320 | −380 | −539 | 0 | — | — |
| Working Capital Days | 164 | 126 | 153 | 132 | 156 | −55.01 | 115 | 21.6 | 184 | −8.35 | — | — |
| ROCE % | 14.19% | 11.83% | 5.02% | 5.9% | 3.24% | −3.04% | −7.15% | −1.25% | −0.77% | −3.29% | 0.83% | 14.65% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fortis Malar Hospitals insights
54 extracted metrics across FY11–FY27.
Documents
Frequently Asked Questions about Fortis Malar Hospitals
What does Fortis Malar Hospitals Ltd do?
Where is Fortis Malar Hospitals Ltd (FORTISMLR) listed?
Which sector does Fortis Malar Hospitals Ltd belong to?
What is the PE ratio of Fortis Malar Hospitals Ltd?
What is the 52-week high and low of Fortis Malar Hospitals Ltd?
Does Fortis Malar Hospitals Ltd pay dividends?
What is the Return on Equity (ROE) of Fortis Malar Hospitals Ltd?
Company Information
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523696.md for Fortis Malar Hospitals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.